Phase 2a Study of HPG1860 in Subjects With NASH

Completed · Phase 2 · Has a placebo group

Conditions studied: NASH - Nonalcoholic Steatohepatitis

In brief

This is a Phase 2a, randomized, double-blind, placebo-controlled, parallel group, multiple arm, multicenter study of 3 different doses of HPG1860 versus placebo in subjects with biopsy-confirmed or phenotypic NASH.

Key facts

Study ID

NCT05338034

Run by

Hepagene (Shanghai) Co., Ltd.

People needed

89

Starts

2021-11-22

Expected to finish

2023-03-28

Last updated by the study team

2026-05-28

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Provision of written informed consent prior to any study-specific procedure.
• Males and females between 18 and 75 years of age
• Nonpregnant, nonlactating women.
• Male subjects must agree to utilize a highly effective method of contraception.
• Body mass index (BMI) of ≥25 kg/m2 at Screening.
• Non-cirrhotic NASH subjects.
• NASH subjects with hepatic fat assessed by a central reader
• Willing and able to adhere to study restrictions and agree to comply with study protocol.

You may not qualify if…

• Pregnant or lactating females
• Current significant alcohol consumption
• Elevated LDL-C with stable dose of statin an or PCSK9 inhibitor
• Renal dysfunction or nephritic syndrome or a history of nephritis
• Recent infarction, unstable angina leading to hospitalization, uncontrolled, symptomatic cardiac arrhythmia
• Uncontrolled hypertension
• Type 1 diabetes or uncontrolled T2DM
• Uncontrolled hypothyroidism
• Liver transplant and/or other significant liver disease or dysfunction
• HIV antibody positive
• Known hypersensitivity or formulation excipient
• Gastrointestinal conditions or procedures that may affect drug absorption
• Hematologic or coagulation disorders
• Unstable weight within the last 3 months
• Active malignancy
• Unexplained creatine kinase (CK) >3 × ULN
• Blood donation, blood transfusion
• Unable to undergo or contraindication to MRI procedure
• A medical or situational finding that in the investigator's opinion may compromise the subject's safety or ability to complete the study.

Where it is running

• South Texas Research Institute (STRI) — Texas City, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.